Alnylam Pharmaceuticals
ALNY
#814
Rank
$31.72 B
Marketcap
$237.10
Share price
0.23%
Change (1 day)
-46.90%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Quarterly Reports

Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2026-q2

Quarterly Report 2026-q2

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q4

Quarterly Report 2025-q4

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2022-q1

Quarterly Report 2022-q1

Language: English

View Quarterly Report